KLK3 and posterior cortical atrophy: To obtain prognostic and survival information and to choose the best therapeutic option, patients affected by PCa are stratified into low-, intermediate-, and high-risk groups based on different clinicopathological characteristics such as the Gleason score (GS) derived from biopsy results, serum prostate-specific antigen (PSA) levels, and clinical stage [3,4].